MAPT and Alzheimer disease: Given our findings that tau preferentially associates with synaptic mitochondria and that non-synaptic mitochondria remain functionally intact, the bioenergetic consequences of synaptic mitochondria-tau interactions may have important contributions to synaptic dysfunctions in AD.